Epilepsy, Generalized Clinical Trial
Official title:
Severity: Quantifying the Severity of Generalized Tonic-clonic Seizures (GTCS) With Connected Devices
By bringing together the fields of seizure detection and that of Sudden Unexpected Death in Epilepsy (SUDEP), the current project aims at delineating which set of biosensors and related biomarkers would optimally characterize the severity of GTCS and the associated risk of SUDEP.
The main objective is to to evaluate which of the five biosignals considered, being, electrodermal activity (EDA), heart rate (HR), accelerometry (AC), arm-measurement of skin electromyography (EMG), and bed sensing of body movement (BM), or any of their combinations, offers the most accurate detection and quantification of our primary indicator of GTCS-severity, i.e. postictal EEG suppression (PGES). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04248920 -
Clinic to Community© Program for Adults With Epilepsy Admitted to Emergency Departments
|
N/A | |
| Completed |
NCT00162981 -
Clobazam in Subjects With Lennox-Gastaut Syndrome
|
Phase 2 | |
| Completed |
NCT00236886 -
Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients
|
Phase 3 | |
| Recruiting |
NCT04959019 -
Exercise for Memory Rehabilitation in Epilepsy
|
N/A | |
| Completed |
NCT00231556 -
A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy
|
Phase 3 | |
| Completed |
NCT04439656 -
Detecting Absence Seizures Using Eye Tracking
|
||
| Completed |
NCT00319501 -
Efficacy and Safety of Vanquix for the Management of Selected, Refractory, Patients With Epilepsy Who Require Intermittent Caregiver Medical Intervention to Control Episodes of Acute Repetitive Seizures.
|
Phase 3 | |
| Completed |
NCT05241678 -
Evaluation of the 24/7 EEG™ SubQ System in Subjects With Uncontrolled Genetic Generalised Epilepsy Syndrome
|
||
| Completed |
NCT00266604 -
A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy
|
Phase 4 | |
| Completed |
NCT00518713 -
Clobazam in Patients With Lennox-Gastaut Syndrome
|
Phase 3 | |
| Recruiting |
NCT06399952 -
Baker Gordon Syndrome Natural History Study
|
||
| Completed |
NCT05297695 -
Helicobacter Pylori Eradication Therapy for Epileptic Children
|
Phase 2/Phase 3 |